The West Virginia Independent Pharmacy Association praised West Virginia Offices of the Insurance Commissioner for holding ...

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...

Earlier this week, the Federal Trade Commission paused its administrative case against major pharmacy benefit managers, including Cigna’s Express Scripts and Evernorth Health, staying proceedings and ...

Cigna’s Express Scripts could be nearing a settlement with the Federal Trade Commission in the agency’s lawsuit accusing the largest pharmacy benefit managers in the U.S. of driving up insulin prices.